Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Inflammatory Bowel Diseases

  Free Subscription

Articles published in J Gastroenterol

Retrieve available abstracts of 20 articles:
HTML format

Single Articles

    March 2022
  1. KISHI M, Hirai F, Takatsu N, Hisabe T, et al
    A review on the current status and definitions of activity indices in inflammatory bowel disease: how to use indices for precise evaluation.
    J Gastroenterol. 2022 Mar 2. pii: 10.1007/s00535-022-01862.
    PubMed     Abstract available

    February 2022
  2. SHIMIZU H, Ebana R, Kudo T, Sato T, et al
    Both fecal calprotectin and fecal immunochemical tests are useful in children with inflammatory bowel disease.
    J Gastroenterol. 2022 Feb 14. pii: 10.1007/s00535-022-01856.
    PubMed     Abstract available

    January 2022
  3. NAKASE H, Hayashi Y, Hirayama D, Matsumoto T, et al
    Interim analysis of a multicenter registry study of COVID-19 patients with inflammatory bowel disease in Japan (J-COSMOS).
    J Gastroenterol. 2022 Jan 28. pii: 10.1007/s00535-022-01851.
    PubMed     Abstract available

  4. MIYOSHI J, Ozaki R, Yonezawa H, Mori H, et al
    Ratio of submucosal thickness to total bowel wall thickness as a new sonographic parameter to estimate endoscopic remission of ulcerative colitis.
    J Gastroenterol. 2022 Jan 24. pii: 10.1007/s00535-021-01847.
    PubMed     Abstract available

    October 2021
  5. ANDO K, Fujiya M, Watanabe K, Hiraoka S, et al
    A nationwide survey concerning the mortality and risk of progressing severity due to arterial and venous thromboembolism in inflammatory bowel disease in Japan.
    J Gastroenterol. 2021 Oct 5. pii: 10.1007/s00535-021-01829.
    PubMed     Abstract available

    September 2021
  6. MIURA M, Shimizu H, Saito D, Miyoshi J, et al
    Multicenter, cross-sectional, observational study on Epstein-Barr viral infection status and thiopurine use by age group in patients with inflammatory bowel disease in Japan (EBISU study).
    J Gastroenterol. 2021 Sep 30. pii: 10.1007/s00535-021-01832.
    PubMed     Abstract available

  7. TOYONAGA T, Kobayashi T, Kuronuma S, Ueno A, et al
    Increased DNA-incorporated thiopurine metabolite as a possible mechanism for leukocytopenia through cell apoptosis in inflammatory bowel disease patients with NUDT15 mutation.
    J Gastroenterol. 2021 Sep 4. pii: 10.1007/s00535-021-01820.
    PubMed     Abstract available

    August 2021
  8. NISHIOKA K, Ogino H, Chinen T, Ihara E, et al
    Mucosal IL23A expression predicts the response to Ustekinumab in inflammatory bowel disease.
    J Gastroenterol. 2021 Aug 27. pii: 10.1007/s00535-021-01819.
    PubMed     Abstract available

    July 2021
  9. MATSUOKA K, Ishikawa H, Nakayama T, Honzawa Y, et al
    Physician-patient communication affects patient satisfaction in treatment decision-making: a structural equation modelling analysis of a web-based survey in patients with ulcerative colitis.
    J Gastroenterol. 2021 Jul 27. pii: 10.1007/s00535-021-01811.
    PubMed     Abstract available

  10. ANDOH A, Kawahara M, Imai T, Tatsumi G, et al
    Thiopurine pharmacogenomics and pregnancy in inflammatory bowel disease.
    J Gastroenterol. 2021 Jul 21. pii: 10.1007/s00535-021-01805.
    PubMed     Abstract available

    May 2021
  11. SHINZAKI S, Matsuoka K, Tanaka H, Takeshima F, et al
    Leucine-rich alpha-2 glycoprotein is a potential biomarker to monitor disease activity in inflammatory bowel disease receiving adalimumab: PLANET study.
    J Gastroenterol. 2021 May 3. pii: 10.1007/s00535-021-01793.
    PubMed     Abstract available

    April 2021
  12. NAKASE H, Uchino M, Shinzaki S, Matsuura M, et al
    Evidence-based clinical practice guidelines for inflammatory bowel disease 2020.
    J Gastroenterol. 2021 Apr 22. pii: 10.1007/s00535-021-01784.
    PubMed     Abstract available

    January 2021
  13. TAKABAYASHI K, Hosoe N, Kato M, Hayashi Y, et al
    Significance of endoscopic deep small bowel evaluation using balloon-assisted enteroscopy for Crohn's disease in clinical remission.
    J Gastroenterol. 2021;56:25-33.
    PubMed     Abstract available

    November 2020
  14. KOHYAMA A, Watanabe K, Sugita A, Futami K, et al
    Ulcerative colitis-related severe enteritis: an infrequent but serious complication after colectomy.
    J Gastroenterol. 2020 Nov 5. pii: 10.1007/s00535-020-01742.
    PubMed     Abstract available

  15. KITA T, Ashizuka S, Ohmiya N, Yamamoto T, et al
    Adrenomedullin for steroid-resistant ulcerative colitis: a randomized, double-blind, placebo-controlled phase-2a clinical trial.
    J Gastroenterol. 2020 Nov 2. pii: 10.1007/s00535-020-01741.
    PubMed     Abstract available

    August 2020
    Solving the questions regarding 5-aminosalitylate formulation in the treatment of ulcerative colitis.
    J Gastroenterol. 2020 Aug 10. pii: 10.1007/s00535-020-01713.
    PubMed     Abstract available

    January 2020
  17. SUGITANI Y, Nishida A, Inatomi O, Ohno M, et al
    Sodium absorption stimulator prostasin (PRSS8) has an anti-inflammatory effect via downregulation of TLR4 signaling in inflammatory bowel disease.
    J Gastroenterol. 2020 Jan 8. pii: 10.1007/s00535-019-01660.
    PubMed     Abstract available

    December 2019
  18. NAGANUMA M, Yokoyama Y, Motoya S, Watanabe K, et al
    Efficacy of apheresis as maintenance therapy for patients with ulcerative colitis in an open-label prospective multicenter randomised controlled trial.
    J Gastroenterol. 2019 Dec 6. pii: 10.1007/s00535-019-01651.
    PubMed     Abstract available

    October 2019
  19. MURAKAMI Y, Nishiwaki Y, Oba MS, Asakura K, et al
    Correction to: Estimated prevalence of ulcerative colitis and Crohn's disease in Japan in 2015: an analysis of a nationwide survey.
    J Gastroenterol. 2019 Oct 23. pii: 10.1007/s00535-019-01637.
    PubMed     Abstract available

    January 2019
  20. YASUKAWA S, Matsui T, Yano Y, Sato Y, et al
    Crohn's disease-specific mortality: a 30-year cohort study at a tertiary referral center in Japan.
    J Gastroenterol. 2019;54:42-52.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.